VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.5600
-0.0068 (-1.20%)
Jan 20, 2026, 9:14 AM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Chronic Inflammatory and Immune-mediated Therapies
501.00K
Log In
Log In
Log In
Log In
Upgrade
Chronic Inflammatory and Immune-mediated Therapies Growth
18.16%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
501.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
18.16%
Log In
Log In
Log In
Log In
Upgrade